| Patient 1 | Patient 2 | |
| Basic attributes | ||
| Age (years) | 61 | 64 |
| Sex | Female | Female |
| Body mass index (kg/m2) | 25.5 | 20.4 |
| Duration of type 2 diabetes (years) | 20 | 10 |
| HbA1c (%) | 10.1† | 7.4‡ |
| Blood glucose (mg/dL) | 328† | 140‡ |
| Complications | ||
| Retinopathy | Simple diabetic retinopathy in both eyes | None |
| Nephropathy (stage) | Stage 1 | Stage 1 |
| Neurological disorder | None | None |
| Hypertension | Present and taking antihypertensive medication | Present and taking antihypertensive medication |
| Dyslipidemia | Present and taking ntihyperlipidemic medication | Present and taking antihyprlipidemic medication |
| Other | None | Angina pectoris at age 58, percutaneous coronary intervention at age 62 |
| Past history | Toxemia of pregnancy at age 27 | Breast cancer and mastectomy at age 50 |
| Prescription | ||
| Diet | Daily limit of 1440 kcal | Manage weight, eat balanced meals, avoid sweets |
| Exercise | Valsalva-type exercise, no intense exercise | Walking 10,000 steps daily is desirable |
| Prescription medicine (mg/day) | Metformin hydrochloride (750) | Acarbose (150) |
| Miglitol (150) | Aspirin (100) | |
| Glimepiride (3) | Bisoprolol fumarate (5) | |
| Candesartan cilexetil (4) | Amlodipine besilate (2.5) | |
| Manidipine hydrochloride (20) | Nicorandil (5) | |
| Rosuvastatin calcium (5) | Rosuvastatin calcium (5) | |
| Lansoprazole (15) | ||